erythroblastosis fetalis

(redirected from hemolytic disease of newborn)
Also found in: Thesaurus, Medical, Legal, Acronyms, Encyclopedia.
Related to hemolytic disease of newborn: erythroblastosis fetalis

erythroblastosis fe·ta·lis

 (fē-tā′lĭs)
n.
A severe hemolytic disease of a fetus or newborn infant caused by the production of maternal antibodies against the fetal red blood cells, usually involving Rh incompatibility between the mother and fetus. Also called RH disease.

[New Latin erythroblastōsis fētālis : erythroblastōsis, erythroblastosis + fētālis, fetal.]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.erythroblastosis fetalis - severe anemia in newborn babies; the result of Rh incompatibility between maternal and fetal blood; typically occurs when the child of an Rh-negative mother inherits Rh-positive blood from the father; can be diagnosed before birth by amniocentesis
anemia, anaemia - a deficiency of red blood cells
References in periodicals archive ?
Chief Executive Officer of Symphogen said, "Sym001, our candidate for the treatment of both Idiopathic Thrombocytopenic Purpura (ITP) and Hemolytic Disease of Newborns (HDN), is planned to enter clinical trials later this year and will be the first recombinant polyclonal antibody product to enter the clinic.
Symphogen's lead product, Sym001, combines 25 different recombinant anti-Rhesus D (RhD) antibodies for the treatment of Idiopathic Thrombocytopenic Purpura (ITP) and the prevention of Hemolytic Disease of Newborns (HDN).

Full browser ?